CKMBITI Human

Creatine Kinase MB Isoenzyme Type-I Human Recombinant
Cat. No.
BT108
Source
Pichia Pastoris.
Synonyms
Creatine Kinase MB Isoenzyme Type-I, CKMBITI, CKMBI, CKMB.
Appearance
Sterile Filtered colorless liquid formulation.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

CKMBITI Human Recombinant produced in Pichia Pastoris is a glycosylated polypeptide chain and a full length Creatine Kinase MB isoenzyme, which is missing the C-terminal Lysine on the M subunit. CKMBITI is a dimeric protein comprised of M and B subunits, having a total Mw of ~44kDa.
The CKMBITI is purified by proprietary chromatographic techniques.

Product Specs

Introduction
Creatine Kinase (CK) exists in three primary forms (isoenzymes): MM, MB, and BB, distributed in muscle, cardiac, and brain tissues, respectively. Recombinant CK proteins are valuable tools for calibrating diagnostic instruments and investigating neuromuscular diseases. These proteins are applicable to research on various neuromuscular conditions, including cardiac disease, mitochondrial disorders, inflammatory myopathies, myasthenia gravis, polymyositis, McArdle's disease, neuromuscular junction disorders, muscular dystrophy, amyotrophic lateral sclerosis (ALS), thyroid disorders (hypothyroidism and hyperthyroidism), central core disease, acid maltase deficiency, myoglobinuria, rhabdomyolysis, motor neuron diseases, rheumatic diseases, and other conditions associated with abnormal CK levels.
Description
Recombinant human CKMBITI, produced in Pichia Pastoris, is a fully glycosylated polypeptide chain encompassing the complete sequence of the Creatine Kinase MB isoenzyme, except for the C-terminal lysine residue on the M subunit. This dimeric protein consists of M and B subunits, resulting in a total molecular weight of approximately 44 kDa. CKMBITI is purified using proprietary chromatographic methods.
Physical Appearance
Sterile, colorless liquid.
Formulation
The protein solution has a concentration of 7.9 mg/ml and is formulated in a buffer containing 0.02 M potassium phosphate, 1 mM dithiothreitol (DTT), and 50% glycerol at a pH range of 5.0-6.0.
Stability
For optimal stability, store CKMBITI below -18°C. While it remains stable at 15°C for up to 7 days, repeated freeze-thaw cycles should be avoided.
Purity
Purity exceeds 95.0% as determined by SDS-PAGE analysis.
Biological Activity
The specific activity is measured at 486 IU/mg at a temperature of 37°C.
Synonyms
Creatine Kinase MB Isoenzyme Type-I, CKMBITI, CKMBI, CKMB.
Source
Pichia Pastoris.

Product Science Overview

Introduction

Creatine kinase (CK) is an enzyme that plays a crucial role in cellular energy homeostasis. It catalyzes the reversible transfer of a phosphate group from adenosine triphosphate (ATP) to creatine, forming phosphocreatine and adenosine diphosphate (ADP). This reaction is vital for the rapid regeneration of ATP, especially in tissues with high and fluctuating energy demands such as skeletal muscle, cardiac muscle, and the brain.

Isoenzymes of Creatine Kinase

Creatine kinase exists in three isoenzymatic forms:

  1. CK-MM: Predominantly found in skeletal muscle.
  2. CK-BB: Mainly present in the brain.
  3. CK-MB: Primarily located in cardiac muscle but also found in smaller amounts in skeletal muscle.

The CK-MB isoenzyme is of particular clinical interest because it serves as a biomarker for myocardial injury, such as that occurring during a heart attack.

Recombinant Human Creatine Kinase MB Isoenzyme

Recombinant human creatine kinase MB isoenzyme (r-hCK-MB) is produced using recombinant DNA technology. This involves the insertion of cDNAs encoding the CK-M and CK-B subunits into a plasmid vector, which is then transformed into a host organism, typically Escherichia coli. The host organism expresses the CK-MB isoenzyme, which can then be purified for various applications.

Production and Purification

The production of r-hCK-MB involves several steps:

  1. Cloning: cDNAs encoding the CK-M and CK-B subunits are amplified using polymerase chain reaction (PCR) and inserted into a plasmid vector.
  2. Transformation: The plasmid vector is introduced into Escherichia coli cells, which then express the CK-MB isoenzyme.
  3. Purification: The expressed CK-MB isoenzyme is purified using conventional chromatography techniques. The purified enzyme retains the key properties of the native cardiac isoenzyme, including its isoelectric point and molecular size .
Applications

Recombinant human CK-MB isoenzyme has several important applications:

  1. Clinical Diagnostics: It is used as a control and calibrator in assays for measuring CK-MB levels in serum, which is crucial for diagnosing myocardial infarction.
  2. Research: It serves as a valuable tool in research related to muscle physiology, energy metabolism, and neuromuscular diseases .
Stability and Storage

The recombinant CK-MB isoenzyme exhibits high stability, retaining over 90% of its activity for at least four months when stored at 11°C in a delipidated serum matrix. This stability makes it a reliable standard for clinical and research applications .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.